Related Experiment Video
Updated: Aug 28, 2025

05:19
Practical Methodology of Cognitive Tasks Within a Navigational Assessment
Published on: June 1, 2015
13.7K
Evaluating Verbal Fluency Outcome Measures in Children With Down Syndrome
Catelyn N Smeyne1, Anna J Esbensen2, Emily K Schworer3
1Catelyn N. Smeyne, Cincinnati Children's Hospital Medical Center.
American Journal on Intellectual and Developmental Disabilities
|September 19, 2022
Summary
This study assessed a verbal fluency task for children with Down syndrome. Semantic trials showed promise for older children (10+ years), but overall reliability needs improvement for clinical trials.
Area of Science:
- Neuropsychology
- Developmental Psychology
- Clinical Trials
Background:
- Children with Down syndrome often require specialized outcome measures for clinical trials.
- Verbal fluency tasks assess cognitive functions like language and executive function.
- Evaluating existing tasks for suitability in this population is crucial.
Purpose of the Study:
- To determine the psychometric properties of a modified verbal fluency task.
- To assess its reliability and feasibility as an outcome measure for children with Down syndrome.
- To explore its correlation with age, IQ, and sex.
Main Methods:
- Eighty-five children with Down syndrome completed a modified verbal fluency task at two time points.
- Psychometric properties including reliability and feasibility were evaluated.
- Correlations with chronological age, IQ, and sex were analyzed.
Main Results:
- The overall verbal fluency measure did not meet predefined reliability and feasibility criteria.
- Feasibility was higher for semantic fluency trials compared to phonemic fluency trials.
- Performance correlated with chronological age and IQ; no sex differences were observed.
Conclusions:
- The semantic verbal fluency trials may be suitable for children with Down syndrome aged 10 and older.
- Further refinement is needed to enhance the overall reliability and feasibility of the task for clinical trials.
- This task shows potential as a targeted outcome measure for specific age groups within the Down syndrome population.

